In particular, the present invention is concerned with compounds of the general formula (I) wherein X, Y and R1 to R10 are as described herein. The compounds are V1a receptor antagonists. The invention also relates to the manufacture of compounds of formula I, pharmaceutical compositions containing them and their use for the treatment of anxiety and depressive disorders and other diseases.
-
Page/Page column 39
(2008/12/06)
More Articles about upstream products of 1039165-99-5
Get Best Price for1039165-99-5(1RS,2R)-N-{(4-Chlorophenyl)[4-(trifluoromethoxy)phenyl]methyl}-1-oxo-1-(1'H,3H-spiro[2-benzofuran-1,4'-piperidin]-1'-yl)propan-2-amine